Ellis Investment Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,046
Closed -$49K 443
2022
Q3
$49K Buy
1,046
+3
+0.3% +$156 0.01% 392
2022
Q2
$52K Buy
1,043
+1
+0.1% +$55 0.01% 401
2022
Q1
$63K Buy
1,042
+215
+26% +$12.8K 0.01% 391
2021
Q4
$54K Buy
827
+1
+0.1% +$64 0.01% 408
2021
Q3
$51K Buy
826
+4
+0.5% +$255 0.01% 395
2021
Q2
$49K Sell
822
-6
-0.7% -$347 0.01% 400
2021
Q1
$45K Hold
828
0.01% 400
2020
Q4
$45K Buy
828
+6
+0.7% +$314 0.01% 386
2020
Q3
$41K Hold
822
0.01% 395
2020
Q2
$36K Hold
822
0.01% 400
2020
Q1
$29K Hold
822
0.01% 366
2019
Q4
$36K Buy
822
+6
+0.7% +$252 0.01% 379
2019
Q3
$33K Hold
816
0.01% 392
2019
Q2
$33K Buy
+816
New +$30.9K 0.01% 380

Other funds holding IHI

Ellis Investment Partners's IHI Position: Q4 2022 in Review

Ellis Investment Partners sold out of iShares US Medical Devices ETF (IHI) in Q4 2022, closing a stake of 1,046 shares — an estimated $49K sold.

Ellis Investment Partners first reported a position in IHI in Q2 2019 and held it in 14 quarters. The position peaked at $63K in Q1 2022. 577 funds tracked by Wall St. Rank hold IHI as of Q4 2022.

  • Ellis Investment Partners reported no remaining iShares US Medical Devices ETF position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 1,046 iShares US Medical Devices ETF shares in Q4 2022, an estimated $49K.
  • Ellis Investment Partners first reported a position in iShares US Medical Devices ETF in Q2 2019 and held it in 14 quarters.
  • Ellis Investment Partners's iShares US Medical Devices ETF position peaked at $63K in Q1 2022.
  • 577 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.